Clinical trials have not yet shown that GLP-1RAs can slow the rate of cognitive decline in mild cognitive impairment and mild dementia due to AD
The spectrum ranges from simple steatosis (fat accumulation) to non-alcoholic steatohepatitis (NASH, now termed MASH or metabolic dysfunction-associated steatohepatitis), which involves inflammation and can progress to cirrhosis and liver failure
When your semaglutide is given by a professional, the results typically become noticeable after the first few injections
Braganza MZ, Kitahara CM, Berrington de Gonzalez A, Inskip PD, Johnson KJ, Rajaraman P
Over the years especially with the additional medical training I've gotten I've learned how to use my GLP-1 effectively, because there's a right and a wrong way to use this medication